On Change with Petro du Pisani
#022 Understanding my desire to be a biotech entrepreneur | Mauritz Venter
16 Jul 2022
A learning journey conversation with a fellow EMBA student. I recently completed an Executive MBA through the University of Cape Town's Graduate School of Business. With classes moving on-line (in 2020 and 2021) due to the covid-19 pandemic there wasn't enough time (for me) to connect with fellow students and hear about their research projects. I decided to interview my fellow students to learn about their research. In this podcast I speak to Dr. Mauritz Venter, CEO and co-founder of AzarGen Biotechnologies about his desire to be a biotech entrepreneur. Being an entrepreneur is risky, and Mauritz wanted to explore why even in spite of uncertainty, risk and anxiety there was nothing else he would rather do. This study followed on from the intense reflective practice which is part of the EMBA course. Delving deeper into his desire to be a biotech entrepreneur he found that this desire was a result of trying to be true to his values in finding a meaningful orientation that would lead to creating a better world. Learn more about UCT's EMBA · Connect with Dr. Mauritz Venter · Connect with Petro · Solid Gold Podcasts
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare